Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA.

J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601.

PMID:
20874515
2.

High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses.

Octaviani CP, Ozawa M, Yamada S, Goto H, Kawaoka Y.

J Virol. 2010 Oct;84(20):10918-22. doi: 10.1128/JVI.01140-10. Epub 2010 Aug 4.

3.

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.

Science. 2010 Aug 27;329(5995):1060-4. doi: 10.1126/science.1192517. Epub 2010 Jul 15.

4.

Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization.

Li YH, Huang S, Du M, Bian Z, Chen Z, Fan MW.

Vaccine. 2010 Jul 19;28(32):5370-6. doi: 10.1016/j.vaccine.2010.04.067. Epub 2010 May 25.

PMID:
20573581
5.

Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009.

Li Y, Shi J, Zhong G, Deng G, Tian G, Ge J, Zeng X, Song J, Zhao D, Liu L, Jiang Y, Guan Y, Bu Z, Chen H.

J Virol. 2010 Sep;84(17):8389-97. doi: 10.1128/JVI.00413-10. Epub 2010 Jun 10.

6.

Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines.

Zhu Y, Lu F, Dai Y, Wang X, Tang J, Zhao S, Zhang C, Zhang H, Lu S, Wang S.

Vaccine. 2010 Jul 19;28(32):5347-55. doi: 10.1016/j.vaccine.2010.05.017. Epub 2010 May 16.

PMID:
20483191
7.

The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination.

Ambrose CS, Wu X, Belshe RB.

Pediatr Infect Dis J. 2010 Sep;29(9):806-11. doi: 10.1097/INF.0b013e3181e2872f.

PMID:
20458256
8.

Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets.

Wang W, Lu B, Zhou H, Suguitan AL Jr, Cheng X, Subbarao K, Kemble G, Jin H.

J Virol. 2010 Jul;84(13):6570-7. doi: 10.1128/JVI.00221-10. Epub 2010 Apr 28.

9.

Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes.

Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ.

Sci Transl Med. 2010 Mar 31;2(25):25ra24. doi: 10.1126/scitranslmed.3000759.

10.

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, Nissen M, Marshall H, Booy R, Heron L, Hartel G, Lai M, Basser R, Gittleson C, Greenberg M.

JAMA. 2010 Jan 6;303(1):37-46. doi: 10.1001/jama.2009.1911. Epub 2009 Dec 21.

PMID:
20026597
11.

Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.

Chen Z, Wang W, Zhou H, Suguitan AL Jr, Shambaugh C, Kim L, Zhao J, Kemble G, Jin H.

J Virol. 2010 Jan;84(1):44-51. doi: 10.1128/JVI.02106-09.

12.

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.

N Engl J Med. 2009 Dec 17;361(25):2405-13. doi: 10.1056/NEJMoa0907413. Epub 2009 Sep 10.

13.

Antibodies against H5 and H9 avian influenza among poultry workers in China.

Wang M, Fu CX, Zheng BJ.

N Engl J Med. 2009 Jun 11;360(24):2583-4. doi: 10.1056/NEJMc0900358. No abstract available.

14.

Avian influenza A H5N1 infections in Bali Province, Indonesia: a behavioral, virological and seroepidemiological study.

Santhia K, Ramy A, Jayaningsih P, Samaan G, Putra AA, Dibia N, Sulaimin C, Joni G, Leung CY, Sriyal J, Peiris M, Wandra T, Kandun N.

Influenza Other Respir Viruses. 2009 May;3(3):81-9.

15.

Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.

Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S.

Vaccine. 2009 Jun 12;27(29):3821-30. doi: 10.1016/j.vaccine.2009.04.008. Epub 2009 Apr 23.

PMID:
19443090
16.

Seroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005.

Dejpichai R, Laosiritaworn Y, Phuthavathana P, Uyeki TM, O'Reilly M, Yampikulsakul N, Phurahong S, Poorak P, Prasertsopon J, Kularb R, Nateerom K, Sawanpanyalert N, Jiraphongsa C.

Emerg Infect Dis. 2009 May;15(5):756-60. doi: 10.3201/eid1505.080316.

17.

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

Huber VC, Thomas PG, McCullers JA.

Vaccine. 2009 Feb 18;27(8):1192-200. doi: 10.1016/j.vaccine.2008.12.023. Epub 2009 Jan 7.

18.

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans.

Jennings LC, Monto AS, Chan PK, Szucs TD, Nicholson KG.

Lancet Infect Dis. 2008 Oct;8(10):650-8. doi: 10.1016/S1473-3099(08)70232-9.

PMID:
18922487
19.

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

Stephenson I, Nicholson KG, Hoschler K, Zambon MC, Hancock K, DeVos J, Katz JM, Praus M, Banzhoff A.

N Engl J Med. 2008 Oct 9;359(15):1631-3. doi: 10.1056/NEJMc0805274. No abstract available.

20.

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.

Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA, Arthos J, Pal R, Markham P, Lu S.

Vaccine. 2008 Jul 23;26(31):3947-57.

Supplemental Content

Support Center